100 related articles for article (PubMed ID: 18302652)
1. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
Schindler F; Lajolo PP; Pinczowski H; Fonseca FL; Barbieri A; Massonetto LH; Katto FT; Del Giglio A
Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
[TBL] [Abstract][Full Text] [Related]
3. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
Morote J; Lorente JA; Encabo G
Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
5. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
Body JJ; Dumon JC; Blocklet D; Darte C
Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
[TBL] [Abstract][Full Text] [Related]
6. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
Woitge HW; Seibel MJ; Ziegler R
Clin Chem; 1996 Nov; 42(11):1796-804. PubMed ID: 8906079
[TBL] [Abstract][Full Text] [Related]
7. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
[TBL] [Abstract][Full Text] [Related]
8. Bone alkaline phosphatase in Paget's disease.
Deftos LJ; Wolfert RL; Hill CS
Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
Watts NB; Jenkins DK; Visor JM; Casal DC; Geusens P
Osteoporos Int; 2001; 12(4):279-88. PubMed ID: 11420777
[TBL] [Abstract][Full Text] [Related]
10. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium cross-links for detection of bone metastases.
Withold W; Georgescu G; Khakzad H; Vosberg H; Mueller-Gaertner HW; Reinauer H
Clin Biochem; 1995 Oct; 28(5):511-9. PubMed ID: 8582050
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.
Takahashi M; Kushida K; Hoshino H; Miura M; Ohishi T; Inoue T
Clin Endocrinol (Oxf); 1997 Aug; 47(2):177-83. PubMed ID: 9302392
[TBL] [Abstract][Full Text] [Related]
13. Bone alkaline phosphatase and mortality in dialysis patients.
Drechsler C; Verduijn M; Pilz S; Krediet RT; Dekker FW; Wanner C; Ketteler M; Boeschoten EW; Brandenburg V;
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1752-9. PubMed ID: 21597029
[TBL] [Abstract][Full Text] [Related]
14. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
Morris PG; Fazio M; Farooki A; Estilo C; Mallam D; Conlin A; Patil S; Fleisher M; Cremers S; Huryn J; Hudis CA; Fornier MN
J Oral Maxillofac Surg; 2012 Dec; 70(12):2768-75. PubMed ID: 22330331
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of occult skeletal metastasis: alkaline phosphatase versus skeletal scintigraphy].
Zieger M
Med Klin Prax; 1982 May; 77(11):44-50. PubMed ID: 7099105
[TBL] [Abstract][Full Text] [Related]
16. A reevaluation of bone scans in breast cancer.
Hayward RB; Frazier TG
J Surg Oncol; 1985 Feb; 28(2):111-3. PubMed ID: 3918216
[TBL] [Abstract][Full Text] [Related]
17. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.
Seaman E; Goluboff ET; Ross S; Sawczuk IS
Urology; 1996 Nov; 48(5):692-5. PubMed ID: 8911510
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
Pectasides D; Farmakis D; Nikolaou M; Kanakis I; Kostopoulou V; Papaconstantinou I; Karamanos NK; Economopoulos T; Raptis SA
J Pharm Biomed Anal; 2005 Feb; 37(1):171-6. PubMed ID: 15664758
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of skeletal AP and PSA with respect to skeletal scintigram in patients with prostatic disease.
Oremek GM; Kramer W; Seiffert UB; Jonas D
Anticancer Res; 1997; 17(4B):3035-6. PubMed ID: 9329594
[TBL] [Abstract][Full Text] [Related]
20. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
